Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.
Barkis
I
I
Molecular Immunopathology/Histocompatibility Laboratory, Onassis Cardiac Surgery Center, Athens, Greece.
Hadjiyannaki-Koniavitou
K
K
Vareltzides
A
A
Hornung
N
N
Raskova
J
J
Degiannis
D
D
D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D015759:Ionomycin / Q000494:pharmacology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D010835:Phytohemagglutinins / Q000494:pharmacology; D011090:Polyenes / Q000494:pharmacology*; D015375:Receptors, Interleukin-2 / Q000187:drug effects / Q000378:metabolism*; D020123:Sirolimus; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism
D007166:Immunosuppressive Agents; D010835:Phytohemagglutinins; D011090:Polyenes; D015375:Receptors, Interleukin-2; D015759:Ionomycin; D016572:Cyclosporine; D004247:DNA; D013755:Tetradecanoylphorbol Acetate; D013936:Thymidine; D020123:Sirolimus